Jonathan R. Keller
Hematopoiesis and Stem Cell Biology Section
The Center for Cancer Research
United States of America
Biography
Dr. Jonathan Keller obtained his Ph.D. under the direction of James Ihle at George Washington University, where he characterized and purified interleukin 3. He has a longstanding interest in the molecular and cellular regulation of hematopoietic cell growth and differentiation.
Research Interest
Cancer Biology, Cell Biology, Molecular Biology and Biochemistry, Stem Cell Biology
Publications
-
Smith JS, Keller JR, Lohrey NC, McCauslin CS, Ortiz M, et al. (1999) Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens. Proc. Natl. Acad. Sci. U.S.A. 96: 8855-60.
-
Ortiz M, Wine JW, Lohrey N, Ruscetti FW, Spence SE, et al. (1999) Functional characterization of a novel hematopoietic stem cell and its place in the c-Kit maturation pathway in bone marrow cell development. Immunity. 10: 173-82.
-
Keller JR, Mantel C, Sing GK, Ellingsworth LR, Ruscetti SK, et al. (1988) Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J. Exp. Med. 168: 737-50.
